Request an invite

Omisirge: how long were the pivotal tox studies?

omidubicel · Expanded cord blood HPC
Longest pivotal study
12 weeks
“Scheduled Sacrifice Time Points Day 1, Week 4, and Week 12 post-transplantation”
✓ VerifiedFDA pharmacology/toxicology review, p. 26Source ↗
Pivotal GLP studies
One GLP single-dose IV toxicity/biodistribution study in irradiated NOD/SCID mice, sacrifices Day 1, Week 4, Week 12
“The following toxicology study was conducted to evaluate the safety of the test article following administration in the NOD/SCID mouse.”
✓ VerifiedFDA pharmacology/toxicology review, p. 25Source ↗
Route in tox
Intravenous (tail vein), single infusion after total body irradiation
“NOD/SCID mice were administered the product via tail vein injection 24 hours after a TBI dose of 300 cGy according to the study groups below.”
✓ VerifiedFDA pharmacology/toxicology review, p. 26Source ↗

Same question, other cell therapies

Abecma

idecabtagene vicleucel · BCMA CAR-T
12 weeks

Alofisel

darvadstrocel · Allogeneic adipose MSC
26 weeks

Amtagvi

lifileucel · TIL therapy
0 (no in vivo tox study)

Aucatzyl

obecabtagene autoleucel · CD19 CAR-T
2 weeks

Breyanzi

lisocabtagene maraleucel · CD19 CAR-T
14 weeks

Carvykti

ciltacabtagene autoleucel · BCMA CAR-T
14 weeks

ChondroCelect

characterised viable autologous cartilage cells · Autologous chondrocytes
53 weeks

Ebvallo

tabelecleucel · EBV-specific allogeneic T cells
20 weeks

Encelto

revakinagene taroretcel · CNTF (encapsulated RPE cell implant)
26 weeks

Gintuit

allogeneic cultured keratinocytes and fibroblasts in bovine collagen · Allogeneic keratinocytes + fibroblasts
52 weeks

Holoclar

autologous corneal epithelial cells containing limbal stem cells · Autologous limbal stem cells
0 (no in vivo tox study)

Kymriah

tisagenlecleucel · CD19 CAR-T
31 weeks

Lantidra

donislecel · Allogeneic pancreatic islets
0 (no in vivo tox study)

MACI

autologous cultured chondrocytes on porcine collagen membrane · Autologous chondrocytes
53 weeks

Provenge

sipuleucel-T · PAP-GM-CSF (autologous APC)
6 weeks

Rethymic

allogeneic processed thymus tissue · Allogeneic thymus tissue
39 weeks

Ryoncil

remestemcel-L · Allogeneic BM-MSC
26 weeks

Spherox

spheroids of autologous matrix-associated chondrocytes · Autologous chondrocyte spheroids
39 weeks

StrataGraft

allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen · Allogeneic keratinocytes + fibroblasts
20 weeks

Tecartus

brexucabtagene autoleucel · CD19 CAR-T
30 weeks

Tecelra

afamitresgene autoleucel · MAGE-A4 TCR-T
0 (no in vivo tox study)

Yescarta

axicabtagene ciloleucel · CD19 CAR-T
30 weeks

Zalmoxis

allogeneic T cells modified with HSV-TK / dLNGFR (nalotimagene carmaleucel) · HSV-TK suicide-gene T cells
3 weeks

Zemcelpro

dorocubicel · UM171-expanded cord blood CD34+
28 weeks

Laviv

azficel-T · Autologous fibroblasts
Not stated in public reviews

Tregzi

allogeneic Treg immunotherapy with HSPC and T cells (Orca-T) · Allogeneic Treg + HSPC + Tcon
Not stated in public reviews

Summary across all 27 cell therapies →